Insiders · Profile

SKIBSTED RUSSELL

Chief Financial Officer at Processa Pharmaceuticals · Chief Financial Officer at Lineage Cell Therapeutics. Filing since 23 Aug 2017. CIK 0001308105

Company
Date
Role
Action
Shares
Amount
Of holding
30 Jun 2026
Chief Financial Officer
Bought
3,277
$6.32K
24.4%
15 Jun 2026
Chief Financial Officer
Bought
2,654
$5.89K
24.7%
29 May 2026
Chief Financial Officer
Bought
2,292
$5.89K
27.1%
15 May 2026
Chief Financial Officer
Bought
1,984
$5.89K
30.6%
30 Apr 2026
Chief Financial Officer
Bought
2,190
$5.89K
50.8%
15 Apr 2026
Chief Financial Officer
Bought
1,984
$5.89K
85.4%
31 Mar 2026
Chief Financial Officer
Bought
2,324
$5.89K
opened
23 Aug 2017
Chief Financial Officer
Bought
2,000
$5.28K
opened
8 decisions on file.